Published in ACS Infectious Diseases · View the paper (DOI)
Researchers developed a peptoid-based therapy that effectively inactivates three enveloped viruses, including Zika, Rift Valley fever and chikungunya virus, by disrupting their membranes. The approach targets specific lipids, allowing for preferential attack on the invader rather than the host.
Coverage from 2 institutions